Why AIDS is Unique: Key Differences from Other Diseases

HIV/AIDS occupies a strange place in the world of infectious diseases. It does not kill people directly the way malaria or cholera might, it does not always show itself the way smallpox or chickenpox did, and decades after its discovery, it still has no vaccine and no complete cure. To understand why public health systems treat HIV with such seriousness, and why families and communities continue to grapple with stigma around it, you have to first understand what makes this disease structurally different from almost every other illness humans face.

A virus that attacks the body’s defence system itself
The CD4 count and the danger threshold
The tuberculosis connection in India
The long, silent incubation period
Why “invisibility” makes HIV harder to control
The window period problem
Transmission tied to intimate behaviour
Stigma as a barrier to prevention
Vulnerability is not evenly distributed
No vaccine, no complete cure
Why a cure is so difficult
Living with HIV as a chronic condition
Bringing the differences together

A virus that attacks the body’s defence system itself

Most diseases attack a specific organ or system. Tuberculosis primarily targets the lungs, hepatitis attacks the liver, dengue affects platelets and blood vessels. HIV is different because it attacks the very system that is supposed to fight off all other diseases. The virus specifically targets CD4 cells, a type of white blood cell that coordinates the body’s immune response. According to the World Health Organization, HIV destroys these CD4 cells, weakening a person’s immunity against opportunistic infections such as tuberculosis, fungal infections, severe bacterial infections, and certain cancers.

This is the first thing that makes AIDS unique. The illness people eventually die from is rarely HIV itself; it is whatever opportunistic infection happens to take advantage of the collapsed immune system. The body becomes a kind of open door that pathogens normally kept out by healthy immunity can now walk through.

The CD4 count and the danger threshold

Doctors track the progress of HIV not by counting the virus alone, but by counting CD4 cells in the blood. A healthy adult typically has 500 to 1,500 CD4 cells per cubic millimetre of blood. As HIV progressively depletes these cells, the risk of opportunistic infection rises. Clinical reviews note that opportunistic infections typically emerge when the CD4 count falls below 200 cells/mm³, the point at which the immune system is severely compromised. This staged collapse is why HIV is not a single sudden illness but a long, sliding loss of defence.

The tuberculosis connection in India

Nowhere is the immune-destruction problem more visible than in the link between HIV and tuberculosis. India carries one of the world’s largest TB burdens, and HIV makes this much worse. The U.S. National Institutes of Health notes that HIV weakens the immune system, increasing the risk of TB in people living with HIV, and that people living with HIV are far more likely to develop active TB disease from a latent infection than people without HIV. Research published in the National Library of Medicine reports that TB remains the leading infectious cause of death in people with HIV, who are 15 to 22 times more likely to contract TB than people without it. For Indian public health, HIV and TB are not two separate problems but one entangled crisis.

The long, silent incubation period

The second feature that sets AIDS apart is timing. Most infectious diseases announce themselves quickly. A person with malaria will usually feel feverish within two weeks of a mosquito bite. A person with the flu will know within days. HIV behaves very differently.

After an initial short flu-like phase, HIV enters what is called the chronic asymptomatic phase. During this period the person looks healthy, feels healthy, and lives a normal life, while the virus quietly continues to replicate and erode the immune system. According to India’s National Guidelines for HIV Testing, this phase lasts on average eight to ten years before the immune system is damaged enough to allow AIDS-defining illnesses to appear.

Why “invisibility” makes HIV harder to control

This long silent period has serious consequences. A person who does not know they are infected may unintentionally transmit the virus to sexual partners, to a baby during pregnancy or childbirth, or through shared needles. Unlike chickenpox or measles, where visible symptoms tell the world to stay away, HIV gives no such warning sign. Indian testing guidelines specifically point out that there is a long asymptomatic period during which the individual is infectious and can spread disease but has no specific symptoms or signs. This is why laboratory testing, not waiting for symptoms, is the only reliable way to detect HIV.

The window period problem

To make matters more complex, there is also a short “window period” right after infection during which antibodies are not yet detectable but the virus is already present and transmissible. A negative test in the first few weeks after exposure does not always mean the person is safe. This combination of an early window and a years-long asymptomatic stage is something few other diseases share.

Transmission tied to intimate behaviour

The third major difference is how HIV spreads. Tuberculosis spreads through coughing. Cholera spreads through contaminated water. Dengue spreads through mosquito bites. These transmission routes are largely involuntary; you cannot easily choose not to breathe air or drink water. HIV, in contrast, mainly spreads through routes that are tied to private, often intimate behaviour: unprotected sexual contact, sharing of injection equipment, and from mother to child during pregnancy, delivery, or breastfeeding.

This creates a public health problem that is fundamentally behavioural. You cannot vaccinate the population and walk away. Prevention depends on people changing how they have sex, how they use drugs, and how they screen blood. It depends on consistent condom use, harm-reduction programmes for injecting drug users, antenatal HIV testing for pregnant women, and safe blood-banking practices.

Stigma as a barrier to prevention

Because the main transmission routes touch on sex and drug use, HIV carries a heavy moral charge in many societies, and especially in conservative settings. Research on HIV stigma in North India describes how stigma and discrimination have been perpetuated by lack of awareness, traditional beliefs, and a moralistic sexual tag. The same study notes that the disease triggers an attitude of fear, shame, blame, and disgrace, making people reluctant to seek testing, disclose their status, or access treatment.

Stigma is not just a social problem; it is a public health problem. When people are afraid of being judged, they avoid testing. When they avoid testing, they do not start treatment. When they do not start treatment, they continue to transmit the virus. The HIV and AIDS (Prevention and Control) Act, 2017 in India was passed precisely to safeguard the rights of people living with HIV, prohibit discrimination in employment, healthcare, and education, and create complaint mechanisms for affected individuals. The fact that such a specific law was needed shows how deeply stigma has shaped the Indian experience of this disease.

Vulnerability is not evenly distributed

Another consequence of the behavioural nature of transmission is that some groups carry far more risk. Indian surveillance data shows elevated HIV prevalence among injection drug users, men who have sex with men, female sex workers, and migrants, which is why NACO’s prevention strategy emphasises targeted interventions for these high-risk groups rather than only general awareness campaigns. This sharp social patterning of risk is much less common in diseases that spread through air or water.

No vaccine, no complete cure

The fourth and perhaps most defining difference is that HIV has no vaccine and no full cure. For most major infectious diseases we have at least one of these two tools. Smallpox was eradicated through vaccination. Polio is close to elimination. Even diseases without vaccines, like cholera, can usually be cured with treatment. HIV breaks this pattern.

The WHO confirms plainly that there is no cure for HIV infection, and current antiretroviral therapy does not cure HIV but allows a person’s immune system to get stronger. People on effective ART can live long, healthy lives and, importantly, will not pass the virus to their sexual partners when their viral load is undetectable. But the treatment must continue every day, for life.

Why a cure is so difficult

The reason HIV cannot yet be cured lies in the biology of the virus itself. HIV integrates its genetic code into the DNA of long-lived immune cells and then goes quiet. Researchers at the Doherty Institute explain that ART does not cure HIV because the virus has the ability to hide and become inactive in a state called latent infection, and once treatment is stopped, the latent virus becomes active again and resumes replication. These hidden viral reservoirs are the central obstacle to a cure. As long as even a small population of latently infected cells survives, the infection can rebound.

Living with HIV as a chronic condition

The good news is that effective treatment has transformed HIV from a death sentence into a manageable chronic illness. The WHO reports that in 2024, 77% of people living with HIV globally were receiving antiretroviral therapy and 73% had suppressed viral loads. India runs one of the largest free ART programmes in the world through NACO, and people who are diagnosed early and treated consistently can expect a near-normal lifespan. The catch is that none of this is curative. It is lifelong management, not resolution.

Bringing the differences together

AIDS is unique because four features stack on top of each other in a way that is rare in medicine. It destroys the immune system rather than any single organ. It hides for years inside apparently healthy people. It spreads through intimate behaviours that carry social stigma. And it has no vaccine and no full cure. Each feature, taken alone, exists in other diseases. It is the combination that makes HIV one of the most challenging public health problems of the past forty years.

This combination also explains why the response to HIV cannot just be biomedical. Drugs alone are not enough. Effective control requires sustained behavioural change, anti-discrimination law, community education, targeted outreach to vulnerable groups, and a healthcare system willing to test and treat without judgment. In other words, HIV is as much a social challenge as a medical one, and that too is part of what makes it different.

What do you think? Given that stigma is one of the biggest barriers to HIV testing and treatment in India, what role should schools, families, and workplaces play in changing how this disease is talked about? And if a vaccine for HIV were to become available tomorrow, do you think the social attitudes around the disease would change quickly, or would the stigma persist regardless?

References

PDF 📄

Why AIDS is Unique: Key Differences from Other Diseases

Table of Contents

A virus that attacks the body’s defence system itself 🔗

The CD4 count and the danger threshold 🔗

The tuberculosis connection in India 🔗

The long, silent incubation period 🔗

Why “invisibility” makes HIV harder to control 🔗

The window period problem 🔗

Transmission tied to intimate behaviour 🔗

Stigma as a barrier to prevention 🔗

Vulnerability is not evenly distributed 🔗

No vaccine, no complete cure 🔗

Why a cure is so difficult 🔗

Living with HIV as a chronic condition 🔗

Bringing the differences together 🔗